HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Roberto Stasi Selected Research

Thrombocytopenic Purpura (Thrombopenic Purpura)

6/2012Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
10/2009Repeated courses of rituximab in chronic ITP: Three different regimens.
3/2009Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
2/2009Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review.
1/2009Pathobiology of secondary immune thrombocytopenia.
1/2009Therapeutic strategies for hepatitis- and other infection-related immune thrombocytopenias.
1/2008Helicobacter pylori and Chronic ITP.
11/2007Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
9/2007Secondary immune thrombocytopenic purpura.
4/2004Management of immune thrombocytopenic purpura in adults.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Roberto Stasi Research Topics

Disease

25Thrombocytopenia (Thrombopenia)
11/2015 - 04/2004
14Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
05/2011 - 05/2002
12Neoplasms (Cancer)
11/2013 - 04/2002
11Infection
04/2014 - 04/2005
11Thrombocytopenic Purpura (Thrombopenic Purpura)
06/2012 - 04/2004
7Hemorrhage
11/2013 - 04/2004
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2013 - 07/2005
5Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2010 - 02/2002
4Hepatocellular Carcinoma (Hepatoma)
12/2012 - 11/2005
4Autoimmune Diseases (Autoimmune Disease)
08/2012 - 01/2009
3Thrombosis (Thrombus)
11/2013 - 05/2010
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2012 - 11/2002
3Liver Diseases (Liver Disease)
07/2010 - 01/2009
3Anemia
09/2009 - 11/2002
3Multiple Myeloma
09/2009 - 11/2002
3Necrosis
11/2005 - 02/2002
2Purpura
11/2015 - 05/2011
2Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
04/2010 - 11/2002
2Neoplasm Metastasis (Metastasis)
04/2008 - 01/2006
2Hematologic Neoplasms (Hematological Malignancy)
11/2002 - 04/2002
1HELLP Syndrome
06/2014
1Opportunistic Infections (Opportunistic Infection)
04/2014
1Oral Ulcer (Mouth Ulcer)
05/2010
1Thrombotic Thrombocytopenic Purpura
04/2010
1Hematologic Diseases (Blood Diseases)
04/2010
1Fistula
10/2009
1Carcinoma (Carcinomatosis)
01/2009
1Colonic Neoplasms (Colon Cancer)
01/2009
1Portal Hypertension
01/2009
1Common Variable Immunodeficiency
01/2009
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2009
1Hepatitis
01/2009
1Hypertension (High Blood Pressure)
04/2008
1Adrenocortical Carcinoma
04/2008
1Weight Loss (Weight Reduction)
04/2008
1Residual Neoplasm
03/2008
1Acute Promyelocytic Leukemia
03/2008
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
02/2008
1Pure Red-Cell Aplasia
12/2007
1Neutropenia
12/2007
1Intravenous Substance Abuse
09/2007
1HIV Infections (HIV Infection)
09/2007
1Leukemia
01/2006
1Colorectal Neoplasms (Colorectal Cancer)
01/2006
1Abdominal Pain (Pain, Abdominal)
01/2006

Drug/Important Bio-Agent (IBA)

32Inosine Triphosphate (ITP)IBA
11/2015 - 11/2002
14rituximab (Mabthera)FDA Link
04/2014 - 05/2002
7eltrombopagFDA Link
12/2010 - 12/2008
6romiplostimFDA Link
11/2013 - 04/2010
4gemtuzumab (gemtuzumab ozogamicin)FDA Link
12/2013 - 01/2006
4AntibodiesIBA
06/2013 - 01/2009
3Thrombopoietin ReceptorsIBA
11/2013 - 01/2009
3Thrombopoietin (c-mpl Ligand)IBA
06/2013 - 01/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2010 - 04/2004
2Antigen-Antibody Complex (Immune Complex)IBA
01/2009 - 04/2004
2Monoclonal AntibodiesIBA
03/2008 - 01/2006
2Immunoconjugates (Immunoconjugate)IBA
03/2008 - 01/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2005 - 02/2002
2infliximab (Remicade)FDA Link
04/2005 - 02/2002
2ErythropoietinFDA Link
11/2003 - 03/2002
1mycophenolate mofetil (Cellcept)FDA LinkGeneric
11/2015
1EnzymesIBA
06/2014
1Reticulin (Reticular Fiber)IBA
11/2013
1SmogIBA
04/2013
1VaccinesIBA
07/2012
1Azathioprine (Imuran)FDA LinkGeneric
12/2010
1Danazol (Azol)FDA LinkGeneric
12/2010
1Prednisolone (Predate)FDA LinkGeneric
05/2010
1StreptokinaseFDA Link
05/2010
1lepirudin (Refludan)FDA Link
05/2010
1AutoantibodiesIBA
04/2010
1thymidine 5'-triphosphate (TTP)IBA
04/2010
1Etoposide (VP 16)FDA LinkGeneric
11/2009
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
11/2009
1AnthracyclinesIBA
11/2009
1Cytarabine (Cytosar-U)FDA LinkGeneric
11/2009
1Daunorubicin (Cerubidine)FDA LinkGeneric
11/2009
1Mitoxantrone (Novantrone)FDA LinkGeneric
11/2009
1Octreotide (Sandostatin)FDA LinkGeneric
10/2009
1Epoetin Alfa (Epogen)FDA Link
09/2009
1Serum AlbuminIBA
06/2009
1HIV AntigensIBA
01/2009
1Immunoglobulin A (IgA)IBA
01/2009
1Hydrocortisone (Cortisol)FDA LinkGeneric
04/2008
1AntigensIBA
03/2008
1HuM195 antibodyIBA
03/2008
1Antiphospholipid AntibodiesIBA
09/2007
1BilirubinIBA
05/2006
1Surface Antigens (Surface Antigen)IBA
01/2006
1Analgesics (Analgesic Drugs)IBA
01/2006

Therapy/Procedure

9Drug Therapy (Chemotherapy)
12/2013 - 11/2002
7Laser Therapy (Surgery, Laser)
12/2012 - 11/2005
4Splenectomy
06/2013 - 04/2004
1Retreatment
10/2009
1Stem Cell Transplantation
02/2008
1Immunotherapy
12/2007
1Blood Transfusion (Blood Transfusions)
09/2007
1Hematopoietic Stem Cell Transplantation
01/2006
1Aftercare (After-Treatment)
01/2006
1Radioimmunotherapy
01/2006